PULMONARY RADIOLOGICAL CHARACTERISTICS IN PATIENTS WITH HIV INFECTION AT THE TIME OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART)

Similar documents
CIBMTR Infection Data and the New Infection Inserts.

Cystic Lung Diseases. Melissa Price Gillian Lieberman, MD Advanced Radiology Clerkship Beth Israel Deaconess Medical Center November, 2008

Appendix E-- The CDC s Current and Proposed Classification System for HIV Infection

Recurrent or Persistent Pneumonia

Appendix B: Provincial Case Definitions for Reportable Diseases

Multi-slice Helical CT Scanning of the Chest

Best Practice Model for Imaging of Community Acquired Pneumonia. Karen E. Conner, MD

Dermatomyositis and interstitial lung disease. Asmin Tulpule, HMS III November 16, 2009 Core Radiology Clerkship

TUBERCULOSIS PLEURAL EFFUSION - MANAGEMENT

Paediatrica Indonesiana. Limitations of the Indonesian Pediatric Tuberculosis Scoring System in the context of child contact investigation

Tuberculosis Exposure Control Plan for Low Risk Dental Offices

Low-dose CT Imaging. Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital

Table. Positive Purified Protein Derivative Results (Pediatrics In Review Apr 2008)

SPONTANEOUS PNEUMOTHORAX AS A COMPLICATION OF SEPTIC PULMONARY EMBOLISM IN AN INTRAVENOUS DRUG USER: A CASE REPORT

Pulmonary infections are an important cause of morbidity and

Online supplements are not copyedited prior to posting.

Incidencia y Características Clínicas del Síndrome Inflamatorio de Reconstitución Inmune (IRIS) en el Contexto de la Coinfección VIH-TB


CT findings in Differential Diagnosis between Tuberculous Pleurisy and Malignant Effusion

Linfoma maligno pulmonar tratado com Nerium oleander. CASE REPORT

PET POSITIVE PLEURAL PLAQUES DECADES AFTER PLEURODESIS: MESOLTHELIOMA? Ellen A. Middleton 1. Jonathan C. Daniel 2. Kenneth S.

Epidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD

TB Intensive San Antonio, Texas November 11 14, 2014

HIV/AIDS Care: The Diagnosis Code Series 2. Prepared By: Stacey L. Murphy, MPA, RHIA, CPC AHIMA Approved ICD-10-CM/ICD-10-CM Trainer

Routine HIV Monitoring

The most important aspect of a tuberculosis (TB) Predicting Active Pulmonary Tuberculosis Using an Artificial Neural Network*

Childhood Tuberculosis: Diagnosis, Treatment and Prevention of TB in HIV-infected Children

Role of Chest CT Scan in Determining Etiology of Primary Spontaneous Pneumothorax

Interim Guidance for Medical Schools on health checks for active and latent Tuberculosis in medical students returning from elective periods overseas

Malignant Pleural Diseases Advances Clinicians Should Know F Gleeson

Lung Cancer Center: How to Achieve JCI

TB Prevention, Diagnosis and Treatment. Accelerating advocacy on TB/HIV 15th July, Vienna

Health Protection Agency position statement on the use of Interferon Gamma Release Assay (IGRA) tests for Tuberculosis (TB)

SMALL CELL LUNG CANCER

Tuberculosis: FAQs. What is the difference between latent TB infection and TB disease?

Maria Dalbey RN. BSN, MA, MBA March 17 th, 2015

TUBERCULOSIS (TB) SCREENING GUIDELINES FOR RESIDENTIAL FACILITIES AND DRUG

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing

GUIDELINES FOR TUBERCULOSIS PREVENTIVE THERAPY AMONG HIV INFECTED INDIVIDUALS IN SOUTH AFRICA

Therapy of pleural effusions Modern techniques

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? Telephone

HIV/AIDS. HIV- Human Immunodeficiency Virus. AIDS immume system severely damaged

What is HIV? What is AIDS? The HIV pandemic HIV transmission Window period Stages of HIV infection

Medullary Renal Cell Carcinoma Case Report

Tuberculosis in Children and Adolescents

Kidney Cancer OVERVIEW

Tuberculosis. Subject. Goal/Objective. Instructions. Rationale. Operations Directorate, Health Branch Immigration Medical Examination Instructions

PLAN OF ACTION FOR. Physician Name Signature License Date

Malignant Mesothelioma Versus Metastatic Carcinoma of the Pleura: A CT Challenge

Corporate Medical Policy Electromagnetic Navigation Bronchoscopy

Clinical description 2 Laboratory test for diagnosis 3. Incubation period 4 Mode of transmission 4 Period of communicability 4

Diagnosis & Treatment Of Cough

International Journal of Case Reports in Medicine

Malpractice and the Infectious Disease Any Physician WHAT YOU SHOULD KNOW! Why this talk? Why me?

CDC TB Testing Guidelines and Recent Literature Update

Mycobacteriosis and HIV infection: the new public health challenge

The Need for Accurate Lung Cancer Staging

Neoplasms of the LUNG and PLEURA

Pulmonary Patterns VMA 976

Elevated Serum Lactate Dehydrogenase Values in Children with Multiorgan Involvements and Severe Febrile Illness

Rheumatic Fever Vs. (?) Post Strep Reactive Arthritis ינואר 2009

Use of Nucleic Acid Amplification Tests in TB patients in California

The Stigma of HIV and AIDS. A Brief History of HIV/AIDS. A Brief History of HIV/AIDS. Opportunistic Infections and Modes of Transmission

Hematologic Malignancies/Stem Cell Transplantation Program Clinical Section UCLA Health System Los Angeles, CA 90095

Challenges in Pediatric Tuberculosis. Mimi Emig, MD Spectrum Health Kent County Health Department

Risk for Tuberculosis in Swiss Hospitals. Content. Introduction. Dr. med. Alexander Turk Zürcher Höhenklinik Wald

Mortality in patients with rheumatoid arthritisassociated interstitial lung disease treated with an anti-tumor necrosis factor agent

Date: Referring Facility: Phone#: Anticipated Patient Needs (Please check appropriate boxes and include details within referral paperwork)

Role of computed tomographic scanning of the thorax prior to bronchoscopy in the investigation of suspected lung cancer

Primary -Benign - Malignant Secondary

Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges

2011 NTP Paediatric guidelines update- final draft

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons

Clinical Scenarios In Childhood TB. Josefina Cadorna Carlos M.D., FPPS, FPIDSP, FSMID Associate Professor of Pediatrics U E R M M M C

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012

Prevention of Acute COPD exacerbations

Journal of Infectious Diseases Advance Access published January 26, 2015

Tuberculosis Prevention and Control Protocol, 2008

Ceftriaxone Therapy Vs. Ciprofloxacin In Treatment Of Typhoid Fever In Adult Patients.

AORTOENTERIC FISTULA. Mark H. Tseng MD Brooklyn VA Hospital February 11, 2005

SARCOIDOSIS. Signs and symptoms associated with specific organ involvement can include the following:

What If I Have a Spot on My Lung? Do I Have Cancer? Patient Education Guide

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla

Desk-guide for diagnosis and management of TB in children

LEARNING OUTCOMES. Identify children at risk of developing TB disease. Correctly manage and refer children suspected of TB. Manage child contacts

Francine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003

There may be up to 5 to 6 million cases of. Treatment Costs of Community- Acquired Pneumonia in an Employed Population*

General Rules SEER Summary Stage Objectives. What is Staging? 5/8/2014

An Update on Lung Cancer Diagnosis

HOVON Staging and Response Criteria for Non-Hodgkin s Lymphomas Page 1

Childhood Cancer in the Primary Care Setting

HIV/AIDS CID 2003:37 (1 December) 1549

What actually is the immune system? What is it made up of?

Pulmonary Complications of Cancer Therapy. Marc B. Feinstein, MD Pulmonary Division Memorial Sloan-Kettering Cancer Center

General Thoracic Surgery ICD9 to ICD10 Crosswalks. C34.11 Malignant neoplasm of upper lobe, right bronchus or lung

Occupational Lung Disease. David Perlman, MD

An overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham

MEDICAL REPORT MEDICAL HISTORY QUESTIONS

Hawaii Administrative Rules. Title 11. Department of Health. Chapter 164. Tuberculosis

Transcription:

August 16, 2007 EU RO PE AN JOUR NAL OF MED I CAL RE SEARCH 341 Eur J Med Res (2007) 12: 341-346 I. Holzapfel Publishers 2007 PULMONARY RADIOLOGICAL CHARACTERISTICS IN PATIENTS WITH HIV INFECTION AT THE TIME OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) T. Schlossbauer 1, G. P. Schmidt 1, J. R. Bogner 2, A. Sing 3, M. F. Reiser 1, C. Becker-Gaab 1 1 Institute of Clincal Radiology, University of Munich LMU, Germany 2 Medizinische Poliklinik, Department of Infectious Diseases, University of Munich LMU, Germany 3 Max von Pettenkofer-Institute for Hygiene and Medical Microbiology, University of Munich LMU, Germany Abstract Objective: To report on radiological and epidemiological characteristics of pulmonary disease in patients with HIV infection in times of highly active antiretroviral therapy (HAART). Methods: Clinical data of 130 HIV infected adults with acute pulmonary symptoms were compared with findings in chest radiography (n = 130) and computed tomography (CT, n = 42). Presence and distribution of consolidation, interstitial changes, pleural effusion, and adenopathy were evaluated. Results were compared to findings from sputum, bronchoalveolar lavage, transbronchial biopsy, or empirical therapy results. Results: 48% of patients presented pathologic findings. Overall sensitivity for the detection of pulmonary involvement was 0.87 (chest radiography) vs. 0.97 (CT). Disease specific sensitivity was 0.33 compared to 0.70. Bacterial pneumonia (BP, n = 26, 20%) was the most frequent diagnosis, followed by pneumocystis jiroveci pneumonia (PJP, n = 17, 13%), mycobacterium avium complex (MAC, 6%), Kaposi s sarcoma and lymphoma (KS and NHL, each 4%), fungal pneumonia (2%), and tuberculosis (TBC, 1%). Focal pulmonary infiltration was predominantly present in BP (50%, n = 13). Reticular (35%; n = 6) and micronodular (35%; n = 6) infiltration were predominantly found in PJP. Conclusions: Despite HAART, lung involvement is still common. Only contrast-enhanced computed tomography shows an acceptable disease-specific sensitivity. In unclear cases, CT should be performed. Key words: Highly Active Antiretroviral Therapy, HIV, pulmonary involvement, pneumonia, plain radiography, computed tomography List of Abbreviations: HAART - Highly Active Antiretroviral Therapy PJP - Pneumocystis jiroveci pneumonia BP Bacterial Pneumonia MAC Mycobacterium Avium Complex KS Kaposi s Sarcoma INTRODUCTION In the developed world, the natural history of HIV infection has changed dramatically in the era of HAART. Different authors described a decreasing incidence of opportunistic infections particularly since introduction of HAART. Regarding PJP, Kaplan et al. reported a decline of 21.5% per year between 1996 and 1998 [1]. For evaluation of epidemiology, patterns of pathology, and therapeutic options, frequently findings from the pre-haart and the post-haart eras of HIV treatment are compared. [2] Many studies evaluating these clinical features are available [3, 4, 5, 6, 7]. However, there are only few recent studies that have evaluated patterns of pulmonary HIV-related disease in chest plain radio graphs and computed tomography (CT). Some data are available on PJP infection. Characteristic patterns of PJP include cystic lung disease, spontaneous pneumo thorax and an upper lobe distribution of parenchymal opacities [8]. However, most information available on morphologic characteristics of different HIV-associated lung diseases is derived from the pre-haart era. The spectrum of pulmonary involvement comprises infective diseases (i.e. BP, PJP, MAC, cytomagalovirus pneumonia, and TBC) and non-infective diseases (i.e. KS, NHL, lung cancer) [9]. The objective of the present study was at first to report on the appearance of lung involvement in patients with pulmonary symptoms in context with CD4 counts, in a second step to compare the sensitivities for different pulmonary manifestations in plain radiography and contrast-enhanced multi-slice CT. Finally, the frequency of radiological findings was collected in order to describe typical radiological patterns for different pulmonary manifestations. MATERIALS, METHODS AND STATISTICS STUDY POPULATION Patients with known HIV infection and pulmonary symptoms were selected from a universitary outpatient clinic and hospital in the city centre of Munich (Germany). The study population included 130 HAARTtreated, HIV infected patients who were referred to the radiology department due to pulmonary symptoms. Symptoms and findings included cough, fever, dyspnea, thoracic pain, rales, hemoptysis, and enlarged palpable axillary lymph nodes (Fig. 1). Cough was the

342 EUROPEAN JOURNAL OF MEDICAL RESEARCH August 16, 2007 Fig. 1. Frequencies (%) of different pulmonary symptoms in HIV-infected patients leading to referral to radiology. most frequent symptom (57%). The mean age of patients was 43.8 years (range 22 77 years). The mean CD4 count was 225/µl (>500/µl 21%, 200-500/µl 35%, <200/µl 44%). Clinical stage was A in 16%, B in 28%, and C in 55% of patients. All patients received HAART during the period under observation. IMAGING Chest radiography (postero-anterior and lateral view) was performed in all 130 individuals at the day of clinical assessment. 42 patients (32%) had additional CT (Somatom Volume Zoom Plus 4, Siemens Medical Solutions, Erlangen, Germany), 10/2.5/5 mm advance / collimation / reconstruction increment.) within maximum 3 days after plain radiography. In a retrospective analysis, standardized evaluation of all images was conducted. The different morphologic aspects taken into account are summarized in Table 1. Table 1. Standardized evaluation of radiological findings. Pleural effusion Yes / No affection Pulmonary interstitial reticular affection nodular reticulo-nodular peribroncholar (interstitial +) alveolar ground glass focal consolidation Two experienced observers (blinded to all clinical data, except HIV infection) reviewed chest radio graphs and CT scans. Each image study was checked for the presence or the absence of the criteria summarized in Table 1. After evaluation of images, the two observers reached a consensus and noted their findings on a standardized check-list (Table 1). Subsequently, definite diagnosis was made under consideration of CD4 counts. CLINICAL PARAMETERS Retrospective evaluation of clinical parameters was performed on each individual. Analysis included standard demographic variables, clinical symptoms at the time of presentation, HAART status, and CD4 cell count. Definite diagnosis of pulmonary involvement (gold standard) required typical findings in bronchoalveolar lavage (BAL) or lung biopsy specimens for PJP. Bacterial (community or hospital acquired) pneumonia was diagnosed in those patients with typical clinical, laboratory, and radiographic presentations, as well as response to antibiotics not expected to treat PJP. A diagnosis of NHL and Kaposi sarcoma required tissue biopsy. Diagnosis of TBC or MAC was confirmed through microbiological evaluation of expectoration and/or gastric juice. STATISTICS Statistical analysis was performed on SPSS (SPSS standard version 14.0; SPSS; Chicago, IL). Frequencies of different radiological findings were calculated. For chest x-ray and CT sensitivity for pulmonary involvement was computed. In a second step, sensitivity for the definite clinical diagnosis was tested. Adenopathy Localization bihilar monhilar apical segments peri-hilar middle segments basal segments RESULTS The frequencies of different clinical diagnoses are summarized in Figure 2. In 35% of patients with pulmonary symptoms no pathology was found in both, clinical examination and radiography. 17% of patients had mild rhino-bronchitis. 48% of patients presented

August 16, 2007 EUROPEAN JOURNAL OF MEDICAL RESEARCH 343 Fig. 2. Frequencies of definite clinical diagnoses (%) of 130 patients with pulmonary symptoms. Rhinobronchitis non-pcp-pneumonia PCP MAC Kaposiʼs sarcoma Lymphoma Miliary TBC No pathology pathologic clinical, microbiological, or histopathologic findings. Bacterial pneumonia (n = 26, 20%) was the most frequent diagnosis within the study population. PJP was the most frequent pathologic finding in BAL and was detected in 13% of patients with pulmonary symptoms (n = 17). Within the entire study population, 9 cases of BAL showed no pathology, but only in 4 of these patients a pulmonary involvement could finally be excluded. False negative results were present in 4 cases with systemic MAC infection (total n = 8). Additionally, in one case of bacterial pneumonia, BAL showed a false negative result. PULMONARY INVOLVEMENT AND CD4 COUNT In the high CD4-count group (>500/µL) only BP was observed. 88% of MAC infections (n = 7) as well as 80% of lymphomas (n = 4) were observed in the low CD4-count group ( 200/µl). Within the intermediate CD4-count group (201 to 500/µl) 9 cases of non-pjp pneumonia, 2 cases of PJP, one case of MAC, one TBC, and one lymphoma were diagnosed (Table 2). Table 2. Frequency of pulmonary manifestations at different CD4 counts. CD4 count 200/µL 201 to 500/µl > 500/ µl BP 50% 35% 15% PJP 88% 12% MAC 88% 12% KS 60% 40% NHL 80% 20% RADIOLOGICAL EVALUATION Overall sensitivity for the detection of pulmonary involvement was 0.87 for chest radiography, and 0.97 for contrast-enhanced CT. Data for the different pulmonary diagnoses are summarized in Table 3. Overall sensitivity for a specific diagnosis was 0.33 for chest radiographs and 0.70 for contrast-enhanced CT (p<0.001). Data for the different pulmonary diagnoses are summarized in Table 4. In patients with radiographic and CT evaluation (n = 42) 13 % of pathologies would have been missed if only chest radiography had been performed. Fig. 3. Frequencies of infiltration patterns in plain radiography (%).

344 EUROPEAN JOURNAL OF MEDICAL RESEARCH August 16, 2007 Table 3. True positive results for pulmonary involvement (non disease-specific). Clinical Diagnosis n Radiography (n = 130) n CT (n = 42) True positive False negative True positive False negative BP 23 20 (87%) 3 9 9 (100%) 0 PJP 17 16 (94%) 1 5 5 (100%) 0 MAC 8 7 (88%) 1 6 6 (100%) 0 KS 5 5 (100%) 0 4 3 (75%) 1 NHL 5 5 (100%) 0 4 4(100%) 0 Table 4. Disease specific true positive results of plain radiography and CT scans. Clinical Diagnosis n Radiography (n = 130) n CT (n = 42) True positive False negative True positive False negative for specific diagnosis for specific diagnosis BP 23 15 (65%) 8 9 8 (89%) 1 PJP 17 11 (65%) 6 5 5 (100%) 0 MAC 8 0 (0%) 8 6 2 (33%) 4 KS 5 1 (20%) 4 4 3 (75%) 1 NHL 5 4 (80%) 1 4 3 (75%) 1 Fig. 4. 57 year old male patient with CDC stage C3 and HAART presented with sub-febrile temperature and dyspnea. Plain radiograph shows a homogenous micro-nodular infiltration pattern. PCR test was positive for mycobacterium tuberculosis. MORPHOLOGIC CHARACTERISTICS AND DISTRIBUTION Different infiltration patterns for each pulmonary manifestation are shown in Figure 3. Focal consolidation was predominantly present in BP (50%, n = 13). Reticular and micronodular infiltration were predominantly found in plain radiographs of patients with PJP. The only case of TBC infection presented a similar micro-nodular infiltration pattern, however nodules tended to be more prominent compared to PJP (Fig. 4). In few cases of BP (n = 3), PJP (n = 2), and MAC (n = 3), plain radiographs showed no infiltrations. In PJP, pulmonary infiltrations were predominantly located in the peri-hilar sections (41%, n = 7) and showed a symmetric distribution (59%; n = 10). KS, which also was mainly located in the peri-hilar region, predominantly demonstrated an asymmetric distribution (80%; n = 4, Fig. 5). In contrast, BP was mainly found in the basal segments (n = 16; 62%) with an asymmetric distribution (n = 18; 69%). Enlarged lymph nodes (> 2cm) were most common in MAC (60%) and NHL (50%). Ground glass attenuation was mainly found in PJP (n = 5). However, there were 12 cases of PJP which did not show a ground

August 16, 2007 EUROPEAN JOURNAL OF MEDICAL RESEARCH 345 Fig. 5. 39-year-old male patient, CDC stage C3: Kaposi sarcoma of the lung with asymmetric peri-bronchovascular infiltration and associated pleural effusion. Fig. 6. Frequency of ground glass infiltration in plain radiography (n). Fig. 7. Frequency of pleural effusion in plain radiography (n). glass pattern (Fig. 6). Ground glass infiltration was not found in BP. Pleural effusion was predominantly found in KS (n = 4, 80%, Fig. 5), and was not at all found in cases of BP (Fig. 7). DISCUSSION Since the introduction of HAART, overall incidences of bacterial pneumonia have significantly decreased [10, 2]. Sullivan et al. (1999) have reported a decline of incidence rates for BP from 22.7 episodes/100 person-years in the first half of 1993 to 9.1 episodes/100 patient years in the second half of 1997 (p < 0.05) [6]. However, in our study population, bacterial pneumonia was still the most frequent pulmonary manifestation, which is consistent with findings from the literature [3]. Relatively to PJP, an increase of BP was reported since introduction of HAART [3, 11]. In the developed world, HAART in combination with anti- PJP prophylaxis has resulted in a significant reduction of PJP. However, the disease still remains the most common AIDS-defining indicator among opportunistic infections [12, 13].

346 EUROPEAN JOURNAL OF MEDICAL RESEARCH August 16, 2007 In the present study population, despite HAART, 17 patients with clinical symptoms had bacteriologically confirmed PJP. 88% of patients with PJP had CD4 counts below 200/µl. Individuals might not respond to HAART in same matter at very low CD4 counts. Only one case of (miliary) tuberculosis (TB) was found. In addition, 8 cases of MAC were confirmed. It has been reported that the incidence of both, TB and MAC, has significantly decreased with HAART. Findings of the present study are therefore consistent with other data from western countries [14]. However, recent progress might be degraded in the future, due to increasing rates of multi-resistant tuberculosis in both, the developing and the developed world. The distribution of pulmonary infiltrations showed different patterns. Bacterial pneumonia predominantly was associated with a typical asymmetric focal consolidation, whereas PJP was primarily located symmetrically in the peri-hilar sections (micro-nodular or reticular pattern). However, all of the here mentioned infiltration patterns were present in PJP and BP (Figure 3). A reliable radiological diagnosis can not be made without knowledge of CD4 counts. Cases of PJP almost only occur, when CD4 counts are below 200/µl. Ground glass attenuation, which has been reported as a strong indicator for PJP, [15] was absent in 12 cases (71%). In 5 patients with clinically confirmed PJP, CT evaluation was performed. Ground glass attenuation was present in CT images in all of these cases. KS was associated with a pleural effusion (80%), and was predominantly located asymmetrically in the basal or peri-hilar sections. The combination of clinical information (HIV infection and CD4-count), pleural effusion and the typical peri-bronchovascular infiltration pattern (low-grade vascular tumor) may be a valuable diagnostic tool for the detection of KS. In times of HAART, pulmonary manifestations still are very common, including PJP, and for certain diseases, typical radiological patterns are observed. There is a good overall sensitivity of plain radiography. However, only contrast-enhanced computed tomography shows an acceptable sensitivity for specific pulmonary diagnoses. In unclear cases with pulmonary symptoms on HIV-infected individuals, contrast-enhanced CT should be performed. REFERENCES 1. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, Holmberg S, Jones JL. Epidemiology of Human Immunodeficiency Virus-Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral Therapy. Clin Infect Dis. 2000 Apr; 30 Suppl 1:S5-14. 2. Boyton RJ. Infectious lung complications in patients with HIV/AIDS. Curr Opin Pulm Med. 2005 May;11(3):203-7. 3. Wolff AJ, O Donnell AE. Pulmonary Manifestations of HIV Infection in the Era of Highly Active Antiretroviral Therapy. Chest. 2001 Dec;120(6):1888-93. 4. Pallela F, Delaney K, Moorman A, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among HIV-infected patients with advanced HIV-infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 Mar 26;338(13):853-60. 5. Wolff AJ, O Donnell AE. HIV-related pulmonary infections: a review of the recent literature. Curr Opin Pulm Med. 2003 May;9(3):210-4 6. Sullivan JH, Moore RD, Keruly JC, Chaisson RE. Effect of Antiretroviral Therapy on the Incidence of Bacterial Pneumonia in Patients with Advanced HIV Infection. Am J Respir Crit Care Med. 2000 Jul;162(1):64-7 7. Taggart S, Breen R, Goldsack N, Sabin C, Johnson M, Lipman M. The changing pattern of bronchoscopy in an HIV-infected population. Chest. 2002 Sep;122(3):878-85. 8. Boiselle PM, Crans CA Jr., Kaplan MA. The changing face of Pneumocystis carinii pneumonia in AIDS patients. AJR Am J Roentgenol. 1999 May;172(5):1301-9. 9. Becker-Gaab C, Kuffer G, Kammer B, Bogner JR. Differential radiologic diagnosis of HIV-associated lung diseases. Bildgebung. 1995 Dec;62(4):302-9. 10. Feikin D, Feldman C, Schuchat A, Janoff E. Global strategies to prevent bacterial pneumonia in adults with HIV infection in the era of highly active antiretroviral therapy. Lancet Infect Dis. 2004 Jul;4(7):445-55. 11. Serraino D, Puro V, Boumis E, Angeletti C, Girardi E, Petrosillo N, Ippolito G. Epidemiological aspects of major opportunistic infections of the respiratory tract in persons with AIDS: Europe, 1993-2000. AIDS. 2003 Sep 26;17(14):2109-16. 12. Beck JM, Rosen MJ, Peavy HH. Pulmonary Complications of HIV Infection. Am J Respir Crit Care Med. 2001 Dec 1;164(11):2120-6. 13. Ahmad A, Khan S, Soubani AO. The findings of Surgical Lung Biopsy in HIV Patients in the Era of Highly Active Antiretroviral Therapy. Ann Thorac Surg. 2005 Jun;79(6): 1862-5. 14. Kirk O, Gatell JM, Mocroft A, Pedersen C, Proenca R, Brettle RP, Barton SE, Sudre P, Phillips AN. Infections with Mycobacterium tuberculosis and Mycobacterium Avium among HIV-infected Patients after the Introduction of Highly Active Antiretroviral Therapy. Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):865-72. 15. Hidalgo A, Falco V, Mauleon S, Andreu J, Crespo M, Ribera E, Pahissa A, Caceres J. Accuracy of high-resolution CT in distinguishing between Pneumocystis carinii pneumonia and non-pneumocystis carinii pneumonia in AIDS patients. Eur Radiol. 2003 May;13(5):1179-84. Epub 2002 Sep 25. Received: February 20, 2007 / Accepted: June 14, 2007 Address for correspondence: Thomas Schlossbauer, MD Institute of Clinical Radiology Pettenkoferstr. 8a